Company / FCF Margin
Serina Therapeutics, Inc. FCF Margin History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-13856.9%
FY2025
5-year range
-13856.9% / -94.5%
FY2021-FY2025
Trend
-14561.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin changed -14562% YoY in FY2025, a notable deviation from the 4-year average annual change of -3621%.
Based on SEC 10-K filings.
-13856.9% in FY2025 with a 5-year CAGR of -13231.9%.
Declined from -94.5% to -13856.9% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -13231.9pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, fcf margin decreased 14561.9% year-over-year.
- Peak fcf margin was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -18.20 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -13856.9% | -14561.9% |
| FY2024 | -94.5% | +0.0% |
| FY2023 | -94.5% | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | -625.1% | -8.9% |
| FY2018 | -574.2% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026